Flash
›
XOMA Royalty Corporation (XOMA) Deep Dive Video
XOMA Royalty Corporation (XOMA) Deep Dive Video
Summary
XOMA is no longer a conventional biotech royalty growth story—it is a tightly bounded merger-arbitrage trade with a $39 cash floor and potentially meaningful Tremfya litigation CVR upside.
View XOMA stock page
·
Read the XOMA research report
Loading the video player…
Loading Flash…